Collett JA - Search Results

1

Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort.

Gearry RB, Roberts RL, Burt MJ, Frampton CM, Chapman BA, Collett JA, Shirley P, Allington MD, Kennedy MA, Barclay ML. Gearry RB, et al. Among authors: collett ja. Inflamm Bowel Dis. 2007 Oct;13(10):1220-7. doi: 10.1002/ibd.20190. Inflamm Bowel Dis. 2007. PMID: 17538984

2

Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.

Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA. Gearry RB, et al. Among authors: collett ja. Dis Colon Rectum. 2004 Mar;47(3):314-22. doi: 10.1007/s10350-003-0049-y. Dis Colon Rectum. 2004. PMID: 14991493

3

Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.

Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA. Gearry RB, et al. Among authors: collett ja. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):563-7. doi: 10.1002/pds.926. Pharmacoepidemiol Drug Saf. 2004. PMID: 15317038

4

High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.

Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, Barclay ML. Gearry RB, et al. Among authors: collett ja. Inflamm Bowel Dis. 2006 Oct;12(10):936-43. doi: 10.1097/01.mib.0000231572.88806.b9. Inflamm Bowel Dis. 2006. PMID: 17012964

5

Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA, Roberts RL, Kennedy MA. Gearry RB, et al. Among authors: collett ja. Aliment Pharmacol Ther. 2003 Aug 15;18(4):395-400. doi: 10.1046/j.1365-2036.2003.01690.x. Aliment Pharmacol Ther. 2003. PMID: 12940924 Free article. Clinical Trial.

6

The significance of haemochromatosis gene mutations in the general population: implications for screening.

Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA. Burt MJ, et al. Among authors: collett ja. Gut. 1998 Dec;43(6):830-6. doi: 10.1136/gut.43.6.830. Gut. 1998. PMID: 9824612 Free PMC article.

7

Adult coeliac disease: prevalence and clinical significance.

Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CM, Chapman BA. Cook HB, et al. Among authors: collett ja. J Gastroenterol Hepatol. 2000 Sep;15(9):1032-6. doi: 10.1046/j.1440-1746.2000.02290.x. J Gastroenterol Hepatol. 2000. PMID: 11059933

8

The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community.

Chapman BA, Burt MJ, Frampton CM, Collett JA, Yeo KH, Wilkinson ID, Cook HB, Barclay MJ, Ross AG, George PM. Chapman BA, et al. Among authors: collett ja. N Z Med J. 2000 Sep 22;113(1118):394-6. N Z Med J. 2000. PMID: 11062814

9

Gallbladder polyps: prospective study.

Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Collett JA, et al. J Ultrasound Med. 1998 Apr;17(4):207-11. doi: 10.7863/jum.1998.17.4.207. J Ultrasound Med. 1998. PMID: 9544602

10

Treatment of chronic hepatitis C with interferon alpha.

Ross AG, Burt MJ, Jennings LC, Collett JA, Walford EJ, Chambers ST, Chapman BA. Ross AG, et al. Among authors: collett ja. N Z Med J. 1995 Mar 22;108(996):101-3. N Z Med J. 1995. PMID: 7715872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page